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A B S T R A C T 
 
 
Introduction:  Routine mammography screening and early detection are important prognostic indicators for breast 
cancer. Geographical and seasonal barriers to mammography services and relationship to breast cancer stage at diagnosis were 
examined. 
Methods:  Travel time to mammography center, seasonal distribution of mammogram use, mammography frequency, and stage of 
cancer were retrospectively examined in 1428 female patients diagnosed with primary breast cancer at a tertiary care clinic system 
in Wisconsin, USA, from 2002 to 2008. 
Results:  Women with no missed mammograms before diagnosis lived a median of 15 minutes from the nearest facility, while those 
who missed five of their past five annual mammograms lived nearly twice as far, with a median travel time of 27 minutes 
(p<0.0001). There was a direct relationship between travel time to nearest mammogram facility and stage of breast cancer at 
diagnosis, with travel time increasing from 17 to 24 minutes for stage 0 and stage 4 breast cancers, respectively 
(p=0.0586). Women were less likely to undergo mammography screening during the winter months (p<0.0001), especially women 
with greater than 30 mi (48.3 km) to travel to the nearest mammogram facility (p=0.0448). 
Conclusions:  In the studied service area, travel time to nearest mammogram center appears inversely related to regular 
mammography screening and breast cancer stage at diagnosis. Mammograms are less common in the winter, especially in women 
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with further to travel. This is the first study to demonstrate that inclement winter weather may impact on screening behaviors in 
rural areas and demonstrates the importance of considering climate as part of geographical access to preventative care. 
 
Key words: breast neoplasms/diagnosis, breast neoplasms/epidemiology, early diagnosis, geographic information systems, 
mammography/statistics, United States/epidemiology. 
 
 
 
Introduction 
 
Routine mammography screening and treatment advances 
have resulted in substantial reductions in breast cancer 
mortality1-3. With the notable exception of the United States 
Preventive Services Task Force (USPSTF)4, most major 
professional organizations, including the American Cancer 
Society, National Comprehensive Cancer Network, 
American College of Radiology, and American Congress of 
Obstetricians and Gynecologists, suggest annual mammogram 
screening in women starting at 40 years of age5-8. 
Additionally, it was recently demonstrated that missing even 
one annual mammogram increases the risk of being diagnosed 
at a later stage9. Despite the prognostic significance of early 
detection10,11, rates of mammography screening in eligible 
women in the USA have reached no higher than 80% and 
rarely exceed 50% in most localities12. Nationwide, the 
average rate of mammography screening for women older 
than 40 years has remained between 50% and 80% since 
200013. Several patient characteristics, including physician 
access, past screening behavior, socioeconomic barriers, 
racial and ethnic differences, and age, have been identified as 
factors that influence mammogram utilization14. The authors 
recently identified travel time as an additional important 
factor, and the issues of geographical access and the influence 
of climate were further explored9. 
 
In rural regions, access to mammography screening can be 
problematic, and several studies suggest that longer travel 
distances adversely affect early detection of breast cancer in 
rural populations15-17. Other studies have reported mixed 
results18-21. Additionally, Oh et al have suggested seasonal 
variation in breast cancer diagnosis, specifically noting a 
trough in breast cancer diagnosis in the winter months22. 
Studies of mammography access by location are improving as 
geographic information systems (GIS) technology is refined to 
more accurately determine point-to-point distance and travel 
time via road networks. The goal of the present study was to 
utilize modern GIS technology to determine the association 
between geographic proximity to mammogram centers and 
breast cancer stage at diagnosis in a single healthcare system 
that serves the majority of residents in north-central 
Wisconsin, USA, a predominantly rural agricultural region. 
In light of the potential for inclement winter weather to affect 
travel conditions in the studied service area, seasonal 
mammogram variability was also explored. 
 
Methods 
 
Patient data 
 
Female patients diagnosed with primary breast cancer at any 
of the over 50 system-wide healthcare facilities between 1 
January 2002 and 30 December 2008 were identified 
electronically through the local cancer registry23. Data 
regarding number of medical encounters during the study 
period, mammograms within the 5 years before breast cancer 
diagnosis, and breast cancer stage at diagnosis were abstracted 
electronically and by manual chart abstraction when 
necessary. Manual validation was performed on 10% of 
records. Patients diagnosed at facilities outside the healthcare 
system, male breast cancer patients, and patients whose 
physical address of residence was located outside of 
Wisconsin and neighboring Illinois, Michigan, and Minnesota 
were excluded. 
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Comprehensive capture of mammogram screening 
information was achieved via electronic search for 
mammogram-related procedure codes (ICD-9 codes 793.8X, 
V76.11, V76.12) and appointment types. Procedure codes 
included codes for computer mammogram add-on, 
radiograph of mammary duct(s), mammogram (one breast, 
both breasts, or screening), computer-aided detection of 
diagnostic or screening mammography, mammary ductogram 
or galactogram multiple, mammography (unilaterial or 
bilateral), screening mammography (bilateral or digital), and 
diagnostic mammography digital. Appointment types 
included 31 mammography-related codes. Most 
mammograms were identified by procedure and radiology 
and/or appointment type (89.7%). All others were manually 
adjudicated to ensure accuracy. Diagnostic mammograms 
were excluded from analyses when done subsequent to a 
screening mammogram. 
 
Screening mammograms were annualized so that number of 
missed mammograms could be determined for each patient. 
For analysis purposes, the number of missed mammograms is 
defined as the number of 1-year (365 days) periods subjects 
went without having at least one mammogram before breast 
cancer diagnosis based on the recommendations of most 
major professional organizations5-8 and recent findings 
demonstrating that missing even one annual mammogram 
results in an increased risk for later stage at diagnosis9. For 
analysis of stage, patients were dichotomized into early- and 
late-stage categories. Patients with stages 0–2 breast cancer 
were considered early stage and patients with stages 3–4 
breast cancer were considered late stage. 
 
Geocoding facility locations 
 
A total of 22 facilities in Wisconsin were included. Facility 
data included name, physical street address, city, state, ZIP 
code, and status as either a fixed screening location or mobile 
screening unit. Facility locations were geocoded as point 
features based on the physical street address of each 
facility. Mobile facilities were geocoded at the location where 
the mammogram screening was conducted. In analyses, no 
distinction was made between fixed and mobile locations, as 
mobile locations are consistent on a recurrent basis. 
 
ESRI ArcGIS Desktop v10.0, ArcInfo license, Business 
Analyst extension, and StreetMap Premium using data from 
TeleAtlas 2010 were used to geocode point features 
(http://www.esri.com/software/arcgis). Business Analyst 
Store Setup wizard was used to determine facility locations 
andArcGIS Geocoding toolbar, Review/Rematch Addresses 
tool was used to substantiate geocoded results. 
 
Geocoded facility locations were validated by comparing 
geocoded point features to full-color orthophotographs 
acquired in 2010 by the National Agricultural Inventory 
Program. Visual inspection verified existence of the facility 
locations. One geocoded facility was found to be misplaced. 
Two distinct geocoded locations identified the same address, 
but in two different counties. The spatial feature was moved 
based on the correct address match. 
 
Geocoding patient residence 
 
Patient residences were geocoded as point features based on 
the physical street address noted in the electronic medical 
record (EMR). ESRI ArcGIS Desktop version 10.0, ArcInfo 
license, Business Analyst extension, and StreetMap Premium 
using data from TeleAtlas 2010 was used to geocode point 
features. Business Analyst, Customer Setup wizard was used 
to initially determine patient residence location. ArcGIS 
Geocoding toolbar, Review/Rematch Addresses tool was 
used to substantiate geocoded results, with a match score of 
100 indicating a best match. A best match is attained when an 
address in the project database matches perfectly with an 
address in the streets. Lower scores indicate inconsistency 
between an address in the two databases. Inconsistencies 
frequently occur due to misspellings, abbreviations (e.g., St., 
Street, or Str.), and street direction (left or right side of the 
street). Other inconsistencies may result from errors in city, 
state, and ZIP code information. 
 
Geocoded features with a score <100 (n=424) were manually 
investigated. Parcel data from Wisconsin counties were used to 
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identify and correct addresses based on the comparison between 
the parcel’s address and the geocoded address. The TerraServer 
online imagery service (http://www.terraserver.com) was used 
to verify an address and acquire latitude and longitude coordinates. 
Latitude and longitude coordinates were used as a substitute for a 
positive address match (ie score of 100). 
 
Patient residences describing a post office box or rural route, or 
with missing or unidentifiable addresses that could not be 
geocoded, were geolocated to the centroid of the patient’s ZIP 
code using the Mean Center tool and ArcToolbox. Geocoded 
residences for 77 patients were documented this way. 
 
A random sample of 100 patient addresses with a geocoded 
score of 100 was inspected further by comparison to 
orthophotographic images, as described above. There were 
96 point features found to have a residence within 500 ft 
(152.4 m) of the geocoded address. Four geocoded addresses 
had a residence identified at a distance >500 ft and two were 
within 1200 ft (365.8 m) of the actual location. The 
remaining two addresses did not have an identifiable 
residence within close proximity to the geolocated address. 
 
Distance to closest facility analysis 
 
The distance to closest facility analysis measured distance and 
time along a road network between a patient and their closest 
mammogram facility, which may or may not have been the 
facility at which they received cancer screening services. ESRI 
ArcGIS Desktop v10, ArcInfo license, and the Network 
Analyst Extension and Toolbar were used to conduct this 
analysis. Parameters shown in Table 1 were applied using 
Network Analyst’s New Closest Facility analysis. The author 
institution’s fixed and mobile facility point features (22 
features) were loaded as the Facilities layer. The result of the 
New Closest Facility analysis created a time and distance 
attribute for each record loaded in the Incidents layer. 
 
Distance to visited facility analysis 
 
The distance to visited facility analysis measured distance and 
time along a road network between a patient and the facility 
where they received cancer screening services, as recorded in 
the EMR. Network Analyst’s New Closest Facility analysis 
was conducted 22 times, once for each fixed and mobile 
facility. Patient records (1421) were extracted into 
22 separate feature classes based on facility visited. 
Parameters shown in Table 2 were applied using Network 
Analyst’s New Closest Facility analysis. The author 
institution’s fixed and mobile facility point features were 
loaded individually as the Facilities layer. Patient residence 
location point features that visited the facility were loaded as 
the Incidents layer. The result of the New Closest Facility 
analysis created a time and distance attribute for each record 
loaded in the 22 Incidents layers. 
 
Of 1421 patients, 482 did not have data recording the facility 
visited for cancer screening services; they were assumed to 
have visited the clinic in the central location, based on project 
data revealing that 746 of 939 (79.4%) patients with a 
recorded facility address visited the facility in the central 
location in Wisconsin. 
 
Seasonal variation 
 
Seasons were defined using northern hemisphere calendar 
dates of equinoxes and solstices: spring (20 March – 19 
June), summer (20 June – 20 September), autumn/fall (21 
September – 20 December), and winter (21 December – 
19 March). The Wisconsin State Climatology Office reports 
mean winter temperature ranges in Wisconsin of 0–20ºF (–
18ºC to –7ºC), with an average monthly snowfall range of 8–
14 inches (20–35 cm) and the potential for 10 or more major 
winter storms per season24. 
 
Statistical analyses 
 
The Wilcoxon rank-sum test was used to analyze differences in 
time to nearest facility in subjects by number of missed 
mammograms and breast cancer stage. Multinomial logit analysis 
was performed to analyze the relationship between later stage 
diagnosis of breast cancer and time to nearest facility for all 
subjects, or time to visited facility for those subjects who had had 
at least one mammogram. To account for factors with the 
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potential to influence mammogram utilization or stage at 
diagnosis, multinomial logit analyses were adjusted for age, 
insurance status, number of medical encounters, comorbidities, 
family history of breast cancer, and calendar year. In addition, χ2 
testing was used to determine whether seasonal mammogram 
distribution was even and if there was an association between 
season and distance to the nearest facility. All analyses were 
conducted using Statistical Analysis System v9.2 software (SAS; 
http://www.sas.com) and p values <0.05 were considered 
significant. 
 
Ethics approval 
 
Institutional Review Board approval was given, with waiver 
of informed consent; ethics approval number ONI11609. 
 
Results 
 
A total of 1428 patients with breast cancer were identified 
systemwide for review, of which seven were excluded for 
incomplete mammography dates. Demographic 
characteristics for patients with and without at least one 
mammogram in the 5 years before breast cancer diagnosis are 
summarized in Table 2, and suggest that women who had at 
least one mammogram were more likely to be older, have 
more comorbidities, live closer to a mammogram facility, 
and to have a known family history of breast cancer. 
 
Mammograms were annualized, and number of missed 
mammograms was assessed with respect to time to the 
nearest facility (Table 3). The difference was significant, and 
women who missed none of their five annual mammograms 
lived a median of 15 minutes from the nearest facility, while 
those who missed five of their past five annual mammograms 
lived nearly twice as far, with a median travel time of 
27 minutes to the nearest facility (p<0.0001) (Table 3). 
Similarly, a trend in the relationship between travel time to 
nearest mammogram facility and stage of breast cancer at 
diagnosis was observed, with travel time increasing as cancer 
stage increased, from a median 17 minutes for subjects with 
stage 0 breast cancer to 24 minutes for subjects with stage 4 
breast cancer (p=0.0586; Fig1). 
Despite the trend toward increasing travel time with increasing 
cancer stage, the odds ratio (OR) of being diagnosed with breast 
cancer at a later stage (stages 3–4) was not significantly increased 
with increasing time to nearest facility or time to visited facility 
(Table 4). However, there was a trend toward increasing OR with 
increasing time to visited facility, reaching 1.63 in women who 
travelled 60 minutes or longer to a mammogram facility 
compared to those who travelled less than 5 minutes. 
 
Analysis of seasonal mammogram distribution revealed 
significantly fewer screening mammograms performed during 
the winter months (Table 5). To investigate the possibility 
that this was related to travel difficulties, seasonal 
mammogram distribution was compared in women with 
distances of 30 mi (48.3 km) or less to the nearest 
mammogram facility to those with greater than 30 mi to 
travel. A significant trend toward decreased mammography 
in the winter months in women with more than 30 mi to 
travel was noted (Table 5), suggesting that winter weather 
may affect geographical access in such women. As healthcare 
providers often recommend annual mammogram screening 
coinciding with birthday, the number of missed 
mammograms by month and season of birth was also 
assessed. No difference was found based on birth month (data 
not shown), suggesting that date of annual mammogram may 
not be tied to season of birth in the system. 
 
Discussion 
 
Routine mammography provides opportunities for earlier 
breast cancer diagnosis. It has been demonstrated that missed 
mammograms, even 1 year before diagnosis, increase risk of 
later stage breast cancer9,25. Evidence suggests that regular 
mammography screening may be limited by geographical 
access to mammography centers, and that longer travel 
distances adversely affect early detection of breast cancer in 
rural populations15-17, although results are mixed18-21. The 
data presented here support the notion that longer travel time 
may be related to missed mammograms and later stage at 
diagnosis of breast cancer. A novel effect of season, whereby 
winter weather appears to result in reduced mammogram 
utilization, is also shown here. 
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Table 1:  Network Analyst’s New Closest Facility analysis parameters for distance to nearest/visited facility 
 
Impedance Time (minutes). Length (miles). 
Facilities to find One 
Travel from Incident (ie patient) to facility 
U-turns at junctions Allowed 
Use hierarchy Yes 
Ignore invalid locations Yes 
Restrictions (one-way) Yes 
Accumulation Time (minutes). Length (miles) 
 
 
 
 
Table 2:  Characteristics of women with and without mammogram in 5 years before breast cancer diagnosis 
 
 Mammogram in 5 years before breast cancer diagnosis?  
 Yes (n=1010) No (n=411) p value 
Age at diagnosis, median (range) 63.7 (30.3–97.8) 60.6 (24.4–97.6) 0.0005 
Charlson score ≥1 48.9% 25.8% <0.0001 
Miles to nearest center, median (range) 7.2 (0.08–152.0) 16.9 (0.3–230.4) <0.0001 
Family history of breast cancer?   <0.0001 
Yes 48.5% 20.2%  
No/missing 51.5% 79.8%  
Insurance   0.0914 
Yes 56.9% 61.8%  
No/missing 43.1% 38.2%  
 
 
 
 
Table 3:  Number of missed annual mammograms and time to nearest facility 
 
Missed 
mammograms† 
n Median time (min) to nearest facility 
(IQR) 
0 278 15.0 (23.0)* 
1 249 13.0 (21.0) 
2 154 13.5 (22.0) 
3 128 14.0 (21.5) 
4 184 15.0 (26.0) 
5 375 27.0 (50.0) 
* p<0.0001 
† Number of 1-year (365 days) periods subject went without having at least one 
mammogram before breast cancer diagnosis. 
IQR, interquartile range 
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Table 4:  Odds ratio of cancer diagnosis at late stage (stage 3–4) by time to nearest or visited facility 
 
Time to facility (min) n OR (95% CI)† p value 
Nearest facility    
 0–5 265 1.00 (ref)  
 5–15 404 0.87 (–0.69–1.45) 0.566 
 15–30 405 1.23 (–0.28–2.00) 0.405 
 30–60 199 1.32 (–0.26–2.27) 0.319 
 ≥60 148 0.82 (–0.83–1.52) 0.525 
Visited facility    
 0–5 256 1.00 (ref)  
 5–15 270 0.72 (–1.10–0.43) 0.335 
 1–30 265 1.41 (–0.33–1.02) 0.721 
 30–60 144 1.38 (–0.46–1.11) 0.627 
 ≥60 58 1.63 (–0.66–1.63) 0.516 
† Adjusted for age, insurance status, number of medical encounters, comorbidity, family history, and calendar year. 
CI, confidence interval. OR, odds ratio 
 
 
 
Table 5:  Seasonal mammogram distribution 
 
Season Mammograms performed 
(n(%)) 
p value 
Spring (20 March –19 June) 1016 (24.4%) <0.0001 
Summer (20 June – 20 September) 1108 (26.6%)  
Fall (autumn) (21 September – 20 December) 1131 (27.2%)  
Winter (21 December – 19 March) 906 (21.8%)  
> 30 miles (48.3 km) from nearest facility 47 (17.0%) 0.0448 
≤ 30 miles from nearest facility 857 (22.2%)  
 
 
 
 
In a recent, large-scale analysis of 161 619 women diagnosed 
with breast cancer around the USA, Henry et al found no 
relationship between travel time to mammogram facility and 
stage of breast cancer at diagnosis26. However, consistent 
with the findings presented here, several other region-specific 
studies have noted effects of travel time or distance on breast 
cancer stage. Huang et al examined distance between 
residence and nearest mammogram facility as a risk factor for 
advanced stage diagnosis in rural Kentucky, finding that 
women with advanced stage cancer had longer average travel 
distances than those diagnosed at an early stage17. Women 
who traveled 15 mi (24.1 km) or more were 1.5 times more 
likely to be diagnosed with late stage disease than those who 
lived within 5 mi (8.0 km) of a mammogram center. 
Additional studies in Kansas and the UK have demonstrated a 
similar relationship between shorter travel distance and early 
detection15,16. Huang et al hypothesized that geographic access 
may be affected by factors other than distance and road 
networks, including topography (eg mountainous terrain) and 
climate (eg heavy snow, icy conditions)17. Geographic area 
may also be associated with other, often unmeasured or 
unquantifiable, variables related to population in residence, 
quality of facilities available, structure of healthcare delivery 
systems, local public health measures, and availability of 
transportation. Therefore, studies that carefully examine a 
given service area, as opposed to nationwide analyses, may be 
warranted for improvement of mammogram utilization. 
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Figure 1:  Stage of breast cancer and distance between patient and nearest mammogram facility. Map portrays 
the stage of breast cancer at diagnosis, as indicated by colored dot, in comparison to physical distance, by street 
network, between place of residence and the closest mammogram facility. Travel time in minutes is indicated by 
shading. 
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The healthcare system described in this study is a 
multicenter, multi-specialty system in north central 
Wisconsin, USA that serves the medical needs of the 
predominately rural community in which it resides. In the 
present study, an inverse relationship between distance from 
the nearest mammogram facility and mammogram utilization 
as well as breast cancer stage at diagnosis was observed. 
Interestingly, this relationship was not linear. The median 
time for women with 0–4 missed mammograms in the 
5 years before breast cancer diagnosis ranged from 
approximately 13–15 minutes. However, when all five 
mammograms were missed, median time nearly doubled. 
The reasons for this lack of linearity are currently unclear, 
but may suggest that a threshold exists somewhere between 
15 and 30 minutes of travel time, or that the group that never 
had a mammogram in the 5 years before diagnosis may be 
more heterogeneous with respect to mammogram frequency 
than those in the other groups. Considering mammography in 
the 5 years before breast cancer diagnosis as a dichotomous 
variable (ie ‘yes’ or ‘no’) may be of interest in this case, 
whereby women who had at least one mammogram during 
this time period had a median travel time of approximately 
14 minutes, whereas those without had a median travel time 
of approximately 27 minutes. 
 
An interesting seasonal distribution of mammogram 
utilization that illustrates the important role climate and 
weather patterns may play in modifying geographical access 
was also noted. Mammogram use was lower in the winter 
than in other months of the year, and this seasonal 
discrepancy was even more prominent in women who lived 
30 minutes or more from the nearest mammogram center. 
Oh et al recently reported globally consistent seasonal 
patterns of breast cancer incidence22. In nearly 3 million cases 
of breast cancer worldwide, diagnoses were significantly 
more common during the spring and autumn/fall in both the 
northern and southern hemispheres. This pattern became 
more prominent as distance from the equator increased, and 
latitude dependence was most pronounced in women living 
in rural areas22. Oh et al proposed a relationship between 
diagnosis and local seasonal changes in the length of the day 
and effects on vitamin D and melatonin levels22. The results 
reported here suggest that impaired travel as a result of 
inclement weather may impede use of mammogram services 
during the winter months and may account for some of the 
trough in breast cancer diagnoses observed during the winter 
in areas further from the equator. Seasonality was more 
pronounced in women living more than 30 minutes from the 
nearest mammogram facility in the present study, consistent 
with Oh et al’s finding that patterns were more pronounced 
in women living in rural areas22. A 2006 study by Celaya et al 
found winter weather to have a negative impact on breast 
cancer treatment in rural New Hampshire, USA27. The same 
group later demonstrated a borderline association between 
diagnosis during the winter months and later stage28; 
however, the present study is the first to describe a potential 
impact of weather on screening behaviors. 
 
Many mammogram reminder programs incorporate reminder 
phone calls or mailed reminder materials coinciding with a 
woman’s birthday29,30. To assess whether such practices 
influenced receipt of mammograms in women born during 
the winter, the effect of month and season of birth of 
mammogram utilization was examined. In the population 
examined here, there was no association between month or 
season of birth and mammogram utilization. However, in 
systems where birthdays or other anniversaries are heavily 
used as reminder triggers, particularly in geographical 
locations where winter weather may be an impediment for 
travel, season and the practice of using birthdays or other 
anniversaries for mammogram reminder programs deserve 
further consideration. 
 
Most studies of travel time and breast cancer stage use 
diagnostic mammogram centers or assume routine 
mammography screening at the nearest facility. In the current 
study, the authors collected information regarding screening 
mammograms over a 5-year period and assessed the 
relationship between both travel time and breast cancer stage 
as well as travel time and routine mammography screening. 
Despite these strengths, limitations include those inherent to 
retrospective studies, namely use of data on hand and as 
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reported. The small number of patients included likely 
explains the failure to reach statistical significance when 
assessing the OR of late stage cancer in patients by travel 
time, despite the trends observed. Also, the authors were 
unable to account for women who sought screening at other 
institutions. However, alternative mammography centers 
outside the authors’ healthcare system are limited or non-
existent in most of the service areas. Additionally, in women 
known to receive mammography services at other 
institutions, the radiology department at the author 
institution obtains reports and films for comparison. An 
additional factor worth consideration is access to 
transportation as a potentially important modifier, especially 
since public transportation is quite limited throughout the 
relatively rural service area. A final limiting factor of this 
study is related to diagnosis of breast cancer in women under 
the age of 40 years. Such women would not be expected to 
receive any screening mammograms prior to breast cancer 
diagnosis. In the current study, 56 of 1421 subjects received a 
diagnosis of breast cancer before they were 40 years old, but 
were included in the analyses. To determine whether this 
may have influenced study results, the authors examined the 
distribution of early- and late-stage breast cancer in women 
younger than 45 years and found that the distribution was 
similar to that of the entire study population, suggesting that 
the inclusion of these women was unlikely to have altered 
study outcomes. 
 
Conclusions 
 
In the rural north-central Wisconsin service area served by 
this healthcare system, travel time to the nearest 
mammogram center appears to be inversely related to regular 
mammography screening and breast cancer stage at 
diagnosis. Mammography screening is undertaken less 
frequently in the winter months, and this seasonal 
discrepancy is even more pronounced in women traveling 
30 minutes or more to the nearest center. Healthcare 
delivery system-specific studies are warranted to investigate 
the factors of greatest importance within a given geographical 
service area. In rural areas, particularly in the northern USA, 
healthcare providers should ask female patients about 
geographic access to mammogram facilities, make 
recommendations for mammogram screening at every visit, 
and consolidate services when possible. Medical assistants and 
appointment coordinators should work to schedule patients 
living further from mammogram facilities at times of the year 
when travel is less likely to be impeded by inclement 
weather. When appointments are canceled or missed during 
the winter months, every effort should be made to contact 
patients and reschedule to ensure annual screening. Plans to 
increase mammogram coverage may be most effective if 
implemented during the non-winter months, and improved 
access to mammography services during the winter may 
require utilization of mobile mammogram units in remote 
areas. Finally, the practices of linking birthday or other 
anniversaries to mammogram reminders may be worth 
further consideration in areas where season may influence a 
patient’s ability to access a facility. 
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